文献速递重症综合管理与镇静镇痛

严重程度校正的ICU死亡率只揭示了一半真相——全国性数据库中治疗限制的影响

Severity-Adjusted ICU Mortality Only Tells Half the Truth-The Impact of Treatment Limitation in a Nationwide Database.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论瑞士ICU患者中13.3%存在治疗限制,校正混杂因素后治疗限制组死亡OR为18.1(95%CI 16.8-19.4),死亡率作为质量指标须考虑治疗限制的存在、程度、原因和时间。

该回顾性观察研究纳入2016-2017年瑞士所有成人ICU共157,625例患者,评估治疗限制的患病率及其对ICU死亡率的影响。结果显示20,916例(13.3%)存在完全定义的治疗限制,其中61%在入ICU时即已确定,48%基于患者预先指示,73%决定故意不给予某些治疗方式。校正相关混杂因素后,治疗限制组的死亡OR为18.1(95%CI 16.8-19.4)。作者结论:每7例瑞士ICU患者中就有1例存在某种治疗限制,这很可能影响严重程度校正的死亡率,死亡率数据作为ICU质量指标或基准时,必须考虑治疗限制的存在、程度、原因和时间才能有意义地解读。

要点

  • 157,625例ICU患者中20,916例(13.3%)存在完全定义的治疗限制,即每7例中约1例。
  • 治疗限制组校正相关混杂因素后死亡OR为18.1(95%CI 16.8-19.4)。
  • 61%(12,854例)的治疗限制在入ICU时即已确定,48%(9,951例)基于患者预先指示。
  • 73%(15,341例)存在故意不给予某些治疗方式的决定。
  • 死亡率作为ICU质量指标或基准时,须考虑治疗限制的存在、程度、原因和时间。

适用人群与场景

  • 2016年和2017年入住瑞士所有成人ICU的患者,共166,764例,排除再入院或编码无效的9,139例后纳入157,625例。

诊断标准与关键阈值

  • 治疗限制定义为完全定义的治疗限制,包括基于患者预先指示的决定(9,951例,48%)和故意不给予某些治疗方式的决定(15,341例,73%);61%(12,854例)在入ICU时即已确定。
  • 原文未提及具体的评分界值或启动/停止阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性观察研究;样本量157,625例ICU患者;人群:2016-2017年瑞士所有成人ICU患者;干预:无;主要终点:治疗限制患病率及其对严重程度校正ICU死亡率的影响。
  • 治疗限制患病率:20,916/157,625(13.3%)。
  • 治疗限制组校正相关混杂因素后死亡OR为18.1(95%CI 16.8-19.4)。
  • 治疗限制的构成:入ICU时即确定12,854例(61%),基于预先指示9,951例(48%),故意不给予某些治疗方式15,341例(73%)。
  • 次要终点包括治疗限制与年龄、性别、入院类型、诊断分组、治疗强度和ICU住院时长的关联,原文摘要未报告具体结果。

证据类型、等级与局限

  • 证据类型:回顾性观察研究;原文未给出证据等级或推荐强度。
  • 原文未述局限性。

对床旁实践的改变

  • 解读ICU死亡率作为质量指标或基准时,须考虑治疗限制的存在、程度、原因和时间,否则严重程度校正的死亡率可能只能反映一半真相。

指南或共识出处

  • Severity-Adjusted ICU Mortality Only Tells Half the Truth-The Impact of Treatment Limitation in a Nationwide Database. Crit Care Med.

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: The influence of different forms of treatment limitation on mortality rate in the ICU is not known despite the common use of the latter as a quality indicator. The aim of the present study was to assess the prevalence of treatment limitation and its influence on ICU mortality rate. Primary outcomes were prevalence of treatment limitation and its influence on severity-adjusted ICU mortality rate. Secondary outcomes included the association of limitation with age, sex, type of admission, diagnostic group, treatment intensity, and length of ICU stay.

DESIGN: Retrospective, observational study.

SETTING: All Swiss adult ICUs.

INTERVENTIONS: None.

PATIENTS: A total of 166,764 patients were admitted to an ICU in 2016 and 2017. Of these, 9139 were excluded because of readmission or invalid coding.

MEASUREMENTS AND MAIN RESULTS: Of 157,625 ICU patients, 20,916 (13.3%) had a fully defined treatment limitation. Among this group, treatment limitation was defined upon ICU admission in 12,854 (61%), the decision to limit treatment was based on the patient's advance directives in 9,951 (48%), and in 15,341 (73%), there was a decision to deliberately withhold certain treatment modalities. The mortality odds ratio for the group with a treatment limitation, considering relevant cofactors, was 18.1 (95% CI 16.8-19.4).

CONCLUSIONS: Every seventh patient in a Swiss ICU has some kind of treatment limitation, and this most probably affects the severity-adjusted mortality rate. Thus, mortality data as a quality indicator or benchmark in intensive care can only meaningfully be interpreted if existence, grade, cause, and time of treatment limitation are taken into account.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kaufmann M, Perren A, Cerutti B, et al. Severity-Adjusted ICU Mortality Only Tells Half the Truth-The Impact of Treatment Limitation in a Nationwide Database. Crit Care Med. 2020. PMID: 33031145. doi:10.1097/CCM.0000000000004658

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。